Taste And Smell TEsting in End Stage Renal Disease

NCT03043144 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2017-06-26

No results posted yet for this study

Summary

Malnutrition is an important complication of advanced kidney disease and impairment in smell and taste may affect nutritional status. This study will examine the association between impairment in smell and taste and nutritional and functional markers among patients with end stage renal disease, as well as risk factors for smell and taste impairment.

Conditions

  • Kidney Failure, Chronic
  • Olfaction Disorders
  • Taste Disorders
  • Malnutrition

Interventions

OTHER

Worsening of olfaction from enrollment visit to 6 months

Worsening of olfaction from enrollment visit to 6 months will be evaluated for association with the primary and secondary outcomes

OTHER

Worsening of taste from enrollment visit to 6 months

Worsening of taste from enrollment visit to 6 months will be evaluated for association with the primary and secondary outcomes

OTHER

Serum Zinc

Serum zinc will be evaluated for association with taste and/or smell impairment

OTHER

Chronic rhinosinusitis

Chronic rhinosinusitis will be evaluated for association with smell impairment

OTHER

Dialysis adequacy

Dialysis adequacy will be evaluated for association with taste and/or smell impairment

OTHER

Decayed missing filled teeth index (DMFT)

DMFT will be evaluated for association with taste impairment

Sponsors & Collaborators

Principal Investigators

  • Katherine Lynch, MD, SM · Beth Israel Deaconess Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-15
Primary Completion
2017-04-01
Completion
2017-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03043144 on ClinicalTrials.gov